Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Jaroslaw Piszcz"'
Autor:
Joanna Zaleska, Paulina Kwasnik, Magdalena Paziewska, Joanna Purkot, Aleksandra Szabelak, Mateusz Jurek, Natalia Masny, Izabela Dziatkiewicz, Bartosz Pronobis‐Szczylik, Agnieszka Piebiak, Agnieszka Szymczyk, Katarzyna Jarosz‐Chudzik, Lukasz Bolkun, Katarzyna Kozlowska, Jaroslaw Piszcz, Edyta Subocz, Janusz Halka, Michal Bator, Elzbieta Kalicinska, Tomasz Wrobel, Lidia Usnarska‐Zubkiewicz, Justyna Rybka, Izabela Deren‐Wagemann, Marta Szyca‐Smieszniak, Jaroslaw Dybko, Iwona Hus, Bartosz Pula, Edyta Cichocka, Marcin Rymko, Dorota Zdunczyk, Mateusz Ziarkiewicz, Grzegorz Wladyslaw Basak, Lars Bullinger, Krzysztof Giannopoulos
Publikováno v:
International Journal of Cancer. 152:705-712
Multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) patients have increased morbidity and mortality rates of COVID-19 due to immunosuppression associated with the disease and ongoing therapy. The same immune impairment accompanying CLL and M
Autor:
Łukasz Bołkun, Bartosz Pula, Agnieszka Kołkowska‐Leśniak, Marta Morawska, Edyta Cichocka, Grzegorz Charlinski, Bartosz Garus, Sebastian Giebel, Jaroslaw Piszcz, Joanna Drozd‐Sokolowska, Jacek Kwiatkowski, Monika Biernat, Iwona Hus, Ewa Lech‐Maranda, Monika Długosz‐Danecka, Krzysztof Giannopoulos, Tomasz Wróbel
Publikováno v:
International Journal of Cancer.
Autor:
Agnieszka Zebrowska, Magdalena Bujno, Barbara Boczkowska-Radziwon, Anna Rogowska, Piotr Radziwon, Jaroslaw Piszcz, Tomasz Wasiluk, Lukasz Bolkun, Kamila Rybinska
Publikováno v:
Journal of Clinical Apheresis
The risk of a hemolytic reaction during the transfusion of ABO non‐identical PC is determined by the presence of natural anti‐A IgM antibodies, the titer of which may increase after infections. The aim of the study was to evaluate the titer of an
Autor:
Agnieszka Pluta, Marta Anna Sobas, Damian Mikulski, Kinga Krawiec, Magdalena Czemerska, Bozena Katarzyna Budziszewska, Tomasz Wróbel, Marzena Watek, Ewa Lech-Marańda, Tomasz Gromek, Dorota Hawrylecka, Marek Hus, Ewa Zarzycka, Jan Zaucha, Anna Armatys, Grzegorz Helbig, Jolanta Oleksiuk, Jaroslaw Piszcz, Andrzej Szczepaniak, Lidia Gil, Rafal Becht, Wojciech Fendler, Sebastian Giebel, Agnieszka Wierzbowska
Publikováno v:
Blood. 140:3206-3207
Autor:
Lukasz Bolkun, Marlena Tynecka, Tomasz Wasiluk, Jaroslaw Piszcz, Aleksandra Starosz, Kamil Grubczak, Marcin Moniuszko, Andrzej Eljaszewicz
Publikováno v:
Journal of clinical medicine. 11(16)
A proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF) are cytokines belonging to the tumor necrosis factor family which play an essential role in B-cell maturation, differentiation, and survival. Recent evidence indicates their
Autor:
Jaroslaw Piszcz, Klaudia Cieśluk
Publikováno v:
Hematology in Clinical Practice. 12:33-35
Chronic myeloid leukemia (CML) is a type of myeloproliferative neoplasm associated with a characteristic chromosomal translocation t(9;22)(q34;q11) which causes the formation of the Philadelphia chromosome (Ph). Therapeutic progress made in the last
Autor:
Anna Waszczuk-Gajda, Lidia Usnarska-Zubkiewicz, Agnieszka Barchnicka, Grzegorz Helbig, Szymon Fornagiel, Dariusz Woszczyk, Pawel Robak, Grzegorz Charliński, Bartosz Małecki, Mirosław Markiewicz, A. Czyż, Janusz Kloczko, Agnieszka Kolkowska, Sebastian Grosicki, Jan Maciej Zaucha, Agata Tyczyńska, Tadeusz Robak, Jarosław Czyż, Artur Jurczyszyn, Anna Kopińska, Dominik Dytfeld, Iwona Hus, Jadwiga Hołojda, Anna Masternak, Jaroslaw Piszcz, Lidia Gil, Tomasz Wróbel, Grzegorz W. Basak
Publikováno v:
Blood. 136:36-37
Background Although the introduction of novel agents improved the survival outcomes in patients with multiple myeloma (MM), some patients died within one year (early mortality, EM) following diagnosis. In this study, we evaluated the EM rate, and inv
Autor:
Bożena Sobkowicz, Włodzimierz J. Musiał, Sławomir Dobrzycki, Jaroslaw Piszcz, Katarzyna Hapaniuk, Tomasz Hirnle, Maciej Mitrosz, Małgorzata Chlabicz, Agnieszka Tycińska, Karol Kamiński
Publikováno v:
Advances in Medical Sciences. 62:378-382
Thrombocytopenia (TP) following transcatheter aortic valve implantation (TAVI) procedure is a common phenomenon but the underlying mechanisms are neither well known nor described. Postinterventional severe TP is related to worse early and late outcom
Autor:
Maciej Kaźmierczak, Izabela Deren-Wagemann, Joanna Góra-Tybor, Agnieszka Pluta, Renata Guzicka-Kazimierczak, Andrzej Szczepaniak, Monika Paluszewska, Jaroslaw Piszcz, Marta Barańska, Elżbieta Patkowska, Olga Grzybowska-Izydorczyk, a Knopińska-Posłuszny, Wiesław Wiktor Jędrzejczak, Ewa Lech-Marańda
Publikováno v:
National Information Processing Institute
Introduction: Central Nervous System involvement (CNSi) in patients with Acute Myeloid Leukemia (AML) rarely occurs. It is not well characterized clinically and lacks standardized treatments. Patients and methods: A retrospective analysis of 77 conse
Autor:
Agnieszka Zebrowska, Anna Rogowska, Jaroslaw Piszcz, Tomasz Wasiluk, Piotr Radziwon, Lukasz Bolkun, Barbara Boczkowska-Radziwon
Publikováno v:
Transfusion and Apheresis Science
Highlights • Pathogen reduction can be an effective method of reducing emerging infectious agents. • Assessment of the effectiveness of pathogen reduction against SARS-CoV-2 is required. • The timing of pathogen reduction should be adapted to t